[Effect of various drugs on platelet aggregation and liberation of platelet factor 4 (anti-heparin factor)].
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects*; D002738:Chloroquine / Q000494:pharmacology; D002951:Citrates / Q000494:pharmacology; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D006494:Heparin Antagonists / Q000378:metabolism*; D007099:Imipramine / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D011817:Rabbits; D012980:Sodium Salicylate / Q000494:pharmacology
D000925:Anticoagulants; D002951:Citrates; D006494:Heparin Antagonists; D010042:Ouabain; D002738:Chloroquine; D005340:Fibrinogen; D010208:Papaverine; D010653:Phenylbutazone; D007099:Imipramine; D012980:Sodium Salicylate; D010646:Phentolamine
Einfluss von verschiedenen Arzneimitteln auf die Thrombozytenaggregation und die Freisetzung des Blutplättchenfaktors 4 (Antiheparinfaktor)